M. Plante

J. Simard, M. Dorval, J. Chiquette, 2004, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

Partnering in Oncogenetic Research – The INHERIT BRCAs Experience: Opportunities and Challenges

B. Knoppers, B. Godard, D. Easton, 2005, Familial Cancer.

Effect of the Women's Health Initiative Study Publication on Hormone Replacement Therapy Use among Women Who Have Undergone BRCA1/2 Testing

J. Simard, M. Dorval, J. Chiquette, 2007, Cancer Epidemiology Biomarkers & Prevention.

Development of a surgical competency assessment tool for sentinel lymph node dissection by minimally invasive surgery for endometrial cancer

G. Hanna, R. Kimmig, A. Mariani, 2021, International Journal of Gynecological Cancer.

Innovations in the treatment of invasive cervical cancer

F. Montz, J. Wharton, P. Rose, 2003, Cancer.

Sentinel node evaluation in gynecologic cancer.

M. Plante, M. Renaud, M. Roy, 2004, Oncology.

Sentinel lymph node biopsy in patients with gynecologic cancers Expert panel statement from the International Sentinel Node Society Meeting, February 21, 2008.

A. V. D. Van Der Zee, A. Schneider, R. Coleman, 2009, Gynecologic oncology.

Multicenter, randomized phase II trial of oral CI-1033 for previously treated advanced ovarian cancer.

A. Oza, H. Hirte, E. Kaldjian, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Simple Vaginal Trachelectomy in Early-Stage Low-Risk Cervical Cancer: A Pilot Study of 16 Cases and Review of the Literature

M. Plante, J. Grégoire, M. Renaud, 2013, International Journal of Gynecologic Cancer.

Pelvic-Floor Properties in Women Reporting Urinary Incontinence After Surgery and Radiotherapy for Endometrial Cancer

H. Moffet, C. Dumoulin, M. Plante, 2017, Physical therapy.

Should ovaries be removed or not in (early-stage) adenocarcinoma of the uterine cervix: a review.

M. Plante, O. Touhami, Omar Touhami, 2015, Gynecologic oncology.

Phase II feasibility study of sequential couplets of Cisplatin/Topotecan followed by paclitaxel/cisplatin as primary treatment for advanced epithelial ovarian cancer: a National Cancer Institute of Canada Clinical Trials Group Study.

E. Eisenhauer, A. Oza, I. Vergote, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Vaginal radical trachelectomy: a valuable fertility-preserving option in the management of early-stage cervical cancer. A series of 50 pregnancies and review of the literature.

M. Plante, M. Renaud, I. Hoskins, 2005, Gynecologic oncology.

Impact of beta blocker medication in patients with platinum sensitive recurrent ovarian cancer-a combined analysis of 2 prospective multicenter trials by the AGO Study Group, NCIC-CTG and EORTC-GCG.

I. Vergote, F. Heitz, P. Harter, 2013, Gynecologic oncology.

Advances and Concepts in Cervical Cancer Trials: A Road Map for the Future

B. Monk, A. Reuss, E. Berns, 2015, International Journal of Gynecologic Cancer.

Data Set for the Reporting of Carcinomas of the Cervix: Recommendations From the International Collaboration on Cancer Reporting (ICCR)

J. Ordi, P. Hui, C. Otis, 2017, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Profiling of endogenous estrogens, their precursors, and metabolites in endometrial cancer patients: association with risk and relationship to clinical characteristics.

C. Guillemette, B. Têtu, P. Ayotte, 2011, The Journal of clinical endocrinology and metabolism.

Laparoscopic Surgery for Endometrial Cancer

B. Rosen, W. Gotlieb, M. Plante, 2010 .

Estradiol metabolites as biomarkers of endometrial cancer prognosis after surgery

C. Guillemette, P. Ayotte, M. Plante, 2017, The Journal of Steroid Biochemistry and Molecular Biology.

Metastatic gastrointestinal tract cancer presenting as ovarian carcinoma.

M. Plante, M. Renaud, M. Roy, 2003, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

First-Line Therapy in Ovarian Cancer Trials

H. Kitchener, J. McAlpine, L. Rubinstein, 2011, International Journal of Gynecologic Cancer.

Integrated digital pathology and transcriptome analysis identifies molecular mediators of T-cell exclusion in ovarian cancer

R. Bourgon, P. Hegde, Yulei N. Wang, 2019, Nature Communications.

Uterine arteriovenous malformations following gestational trophoblastic neoplasia: a systematic review.

M. Plante, X. Trinh, J. Grégoire, 2014, European journal of obstetrics, gynecology, and reproductive biology.

Circulating estrogens in endometrial cancer cases and their relationship with tissular expression of key estrogen biosynthesis and metabolic pathways.

C. Guillemette, B. Têtu, P. Ayotte, 2010, The Journal of clinical endocrinology and metabolism.

Prognostic significance of HER‐2/neu expression in advanced epithelial ovarian cancer: A multivariate analysis

S. Rubin, M. Plante, G. Wong, 1993, American journal of obstetrics and gynecology.

Profiling of Endogenous Estrogens, Their Precursors, and Metabolites in Endometrial Cancer Patients: Association with Risk and Relationship to Clinical Characteristics.

C. Guillemette, P. Ayotte, J. Brisson, 2011, Endocrinology.

A phase II trial of JM-216 in cervical cancer: an NCIC CTG study.

L. Seymour, H. Hirte, D. Lebwohl, 2002, Gynecologic oncology.

Gene expression profiling of paired ovarian tumors obtained prior to and following adjuvant chemotherapy: molecular signatures of chemoresistant tumors.

B. Têtu, D. Bachvarov, M. Plante, 2006, International journal of oncology.

Local expression of cytokines in rat bladder carcinoma tissue after intravesical treatment withNocardia rubra cell wall skeleton and bacille-Calmette-Guerin

G. Jakse, G. Gastl, M. Plante, 2004, Urological Research.

Surgical venous thromboprophylaxis: a cross-sectional survey of canadian gynaecologic oncologists.

Vilma A. Luna, W. Gotlieb, M. Plante, 2012, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

Paraneoplastic syndromes associated with gynecological cancers: A systematic review.

M. Plante, J. Grégoire, M. Renaud, 2017, Gynecologic oncology.

Successful treatment of metastatic renal cell carcinoma with a nonmyeloablative allogeneic peripheral-blood progenitor-cell transplant: evidence for a graft-versus-tumor effect.

N. Hensel, J. Tisdale, R. Childs, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Usefulness of Canadian Public Health Insurance Administrative Databases to Assess Breast and Ovarian Cancer Screening Imaging Technologies for BRCA1/2 Mutation Carriers

J. Simard, S. Pelletier, M. Dorval, 2016, Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes.

Radical vaginal trachelectomy

M. Plante, M. Roy, 2018, An Atlas of Gynecologic Oncology.

Neoadjuvant chemotherapy followed by vaginal radical trachelectomy in bulky stage IB1 cervical cancer: case report.

K. Swenerton, S. Lau, M. Plante, 2006, Gynecologic oncology.

Ovarian cancer in the elderly patient: are we doing enough?

M. Plante, J. Grégoire, M. Renaud, 2010, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

Fertility preservation in the management of gynecologic cancers

M. Plante, 2000, Current opinion in oncology.

Sentinel lymph node (SLN) isolated tumor cells (ITCs) in otherwise stage I/II endometrioid endometrial cancer: To treat or not to treat?

E. Tanner, M. Plante, E. Rossi, 2018, Gynecologic oncology.

Gemcitabine/carboplatin (GC) vs. carboplatin (C) in platinum sensitive recurrent ovarian cancer (OVCA). Results of a Gynecologic Cancer Intergroup randomized phase III trial of the AGO OVAR, the NCIC CTG and the EORTC GCG

E. Eisenhauer, R. Kimmig, H. Hirte, 2004 .

E. Eisenhauer, R. Kimmig, H. Hirte, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Is a More Comprehensive Surgery Necessary in Patients With Uterine Serous Carcinoma?

M. Plante, X. Trinh, J. Grégoire, 2015, International Journal of Gynecologic Cancer.

Estimation risk of lymph nodal invasion in patients with early-stage cervical cancer: Cervical cancer application

X. Paoletti, A. Feki, P. Mathevet, 2022, Frontiers in Oncology.

Cervix Cancer in Sub-Saharan Africa: An Assessment of Cervical Cancer Management

D. Gaffney, M. Plante, F. Lécuru, 2021, JCO global oncology.

Bulky Early-Stage Cervical Cancer (2-4 cm Lesions): Upfront Radical Trachelectomy or Neoadjuvant Chemotherapy Followed by Fertility-Preserving Surgery

M. Plante, 2015, International Journal of Gynecologic Cancer.

Surgical Management of an Adnexal Mass Suspicious for Malignancy These clinical practice guidelines

M. Plante, 2000 .

Role of immunohistochemical overexpression of matrix metalloproteinases MMP-2 and MMP-11 in the prognosis of death by ovarian cancer.

B. Têtu, I. Bairati, M. Beauchemin, 2008, American journal of clinical pathology.

[Radical vaginal trachelectomy for invasive cervical cancer].

M. Plante, M. Roy, 2000, Journal de gynecologie, obstetrique et biologie de la reproduction.

Low BRCA1/2 germline mutation rate in a French-Canadian population with a diagnosis of epithelial tubo-ovarian carcinoma.

M. Plante, J. Grégoire, M. Renaud, 2022, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

High-grade endometrial carcinoma limited to the endometrium or a polyp: is adjuvant treatment necessary?

M. Plante, J. Grégoire, M. Renaud, 2021, International Journal of Gynecological Cancer.

The utility of sentinel lymph node mapping in the management of endometrial atypical hyperplasia.

M. Plante, J. Grégoire, M. Renaud, 2017, Gynecologic oncology.

Combined laparoscopic and vaginal radical surgery in cervical cancer.

M. Plante, M. Renaud, M. Roy, 2000, Gynecologic oncology.

Operative laparoscopy prior to a pelvic exenteration in patients with recurrent cervical cancer.

M. Plante, M. Roy, 1998, Gynecologic oncology.

Preoperative CA 125 tumour marker in endometrial cancer: correlation with advanced stage disease.

M. Plante, J. Grégoire, M. Renaud, 2010, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

Mucinous Ovarian Tumors of Mullerian-type: An Analysis of 17 Cases Including Borderline Tumors and Intraepithelial, Microinvasive, and Invasive Carcinomas

B. Têtu, M. Plante, M. Renaud, 2005, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Olaparib plus paclitaxel plus carboplatin (P/C) followed by olaparib maintenance treatment in patients (pts) with platinum-sensitive recurrent serous ovarian cancer (PSR SOC): A randomized, open-label phase II study.

H. Mackay, A. Oza, H. Hirte, 2012 .

Predicting recurrence and recurrence‐free survival in high‐grade endometrial cancer using machine learning

J. Kwon, S. Lau, W. Gotlieb, 2022, Journal of Surgical Oncology.

Early cervical carcinoma and fertility-sparing treatment options: MR imaging as a tool in patient selection and a follow-up modality.

M. Plante, G. St-Laurent, P. Noël, 2014, Radiographics : a review publication of the Radiological Society of North America, Inc.

Laparoscopic sentinel node mapping in early-stage cervical cancer.

B. Têtu, M. Plante, F. Harel, 2003, Gynecologic oncology.

Simple vaginal trachelectomy in women with early-stage low-risk cervical cancer who wish to preserve fertility: the new standard of care?

M. Plante, J. Grégoire, M. Renaud, 2020, International Journal of Gynecological Cancer.

HRT use among women tested for BRCA1/2 mutations following publication of the women's health initiative study results.

J. Simard, M. Dorval, J. Chiquette, 2005, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

A Phase I Trial of Pox PSA vaccines (PROSTVAC®-VF) with B7-1, ICAM-1, and LFA-3 co-stimulatory molecules (TRICOM™) in Patients with Prostate Cancer

R. DiPaola, D. Petrylak, H. Kaufman, 2006, Journal of Translational Medicine.

Development, Implementation, and Evaluation of a Distance Learning and Telementoring Program for Cervical Cancer Prevention in Cameroon

S. Shete, L. Foxhall, E. Hawk, 2022, JAMA network open.

MANAGEMENT OF T HE ABNORMAL ~APANICOLAOU SMEAR These guidelines have been prepared by the SOGC/GOC/SCC Policy and Practice Guidelines Committee and approved by Council.

M. Plante, T. Ehlen, M. Heywood, 1998 .

A prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancer.

V. Gebski, R. Simes, J. Ledermann, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Comparison of outcomes between abdominal, minimally invasive and combined vaginal-laparoscopic hysterectomy in patients with stage IAI/IA2 cervical cancer: 4C (Canadian Cervical Cancer Collaborative) study.

G. Pond, J. Kwon, L. Elit, 2021, Gynecologic oncology.

The vaginal radical trachelectomy: an update of a series of 125 cases and 106 pregnancies.

M. Plante, J. Grégoire, M. Renaud, 2011, Gynecologic oncology.

A two-stage, single-arm, phase II study of EGCG-enriched green tea drink as a maintenance therapy in women with advanced stage ovarian cancer.

I. Bairati, D. Bachvarov, A. Doyen, 2013, Gynecologic oncology.

Specificity and regioselectivity of the conjugation of estradiol, estrone, and their catecholestrogen and methoxyestrogen metabolites by human uridine diphospho-glucuronosyltransferases expressed in endometrium.

Fernand Labrie, Bernard Têtu, Olivier Bernard, 2004, The Journal of clinical endocrinology and metabolism.

Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers

J. S. Hoffman, W. Chung, V. Pankratz, 2012, Human mutation.

Advancing clinical research globally: Cervical cancer research network from Mexico

D. Gaffney, C. Pérez-Plasencia, L. Mileshkin, 2018, Gynecologic oncology reports.

Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial.

H. Mackay, A. Oza, J. Barrett, 2015, The Lancet. Oncology.

BCAT1 expression associates with ovarian cancer progression: possible implications in altered disease metabolism

C. Guillemette, B. Vanderhyden, D. Bachvarov, 2015, Oncotarget.

The Cervical Cancer Research Network (Gynecologic Cancer InterGroup) roadmap to expand research in low- and middle-income countries

D. Gaffney, M. Plante, D. Tan, 2021, International Journal of Gynecological Cancer.

Cervical cancer in Eastern Europe: review and proceedings from the Cervical Cancer Research Conference

D. Gaffney, M. Plante, G. Peltecu, 2020, International Journal of Gynecological Cancer.

The Cervix Cancer Research Network: A Global Outreach Effort on Behalf of the Gynecologic Cancer InterGroup.

H. Kitchener, W. Small, D. Gaffney, 2015, International journal of radiation oncology, biology, physics.

HtrA1 expression and the prognosis of high-grade serous ovarian carcinoma: a cohort study using digital analysis

I. Bairati, S. Turcotte, M. Plante, 2018, Diagnostic Pathology.

Development of a 3D functional assay and identification of biomarkers, predictive for response of high-grade serous ovarian cancer (HGSOC) patients to poly-ADP ribose polymerase inhibitors (PARPis): targeted therapy

D. Bachvarov, J. Masson, M. Plante, 2020, Journal of Translational Medicine.

Global methylation profiling in serous ovarian cancer is indicative for distinct aberrant DNA methylation signatures associated with tumor aggressiveness and disease progression.

A. Mes-Masson, D. Bachvarov, E. Paquet, 2013, Gynecologic oncology.

The RUNX1 transcription factor is expressed in serous epithelial ovarian carcinoma and contributes to cell proliferation, migration and invasion

D. Bachvarov, M. Plante, X. Trinh, 2013, Cell cycle.

Microarray-Based Oncogenic Pathway Profiling in Advanced Serous Papillary Ovarian Carcinoma

E. Berns, P. V. van Dam, D. Peeters, 2011, PloS one.

Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer

B. Knoppers, B. Godard, D. Easton, 2006, Journal of Medical Genetics.

Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families

D. Labuda, S. Tavtigian, J. Simard, 2006, BMC Cancer.

No Evidence of BRCA 1 / 2 Genomic Rearrangements in High-Risk French-Canadian Breast / Ovarian Cancer Families

M. Dumont, J. Simard, D. Goldgar, 2009 .

No Evidence of BRCA1/2 genomic rearrangements in high-risk French-Canadian breast/ovarian cancer families.

M. Dumont, J. Simard, D. Goldgar, 2006, Genetic testing.

A new alternative splice variant of BRCA1 containing an additional in-frame exon.

M. Dumont, J. Simard, Y. Labrie, 2005, Biochimica et biophysica acta.

Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer

I. Bairati, D. Bachvarov, S. Turcotte, 2019, PloS one.

Interleukin‐6 level in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer

S. Rubin, M. Plante, G. Wong, 1994, Cancer.

Altered expression of different GalNAc‑transferases is associated with disease progression and poor prognosis in women with high-grade serous ovarian cancer.

D. Bachvarov, M. Plante, J. Grégoire, 2017, International journal of oncology.

Suppression of the grainyhead transcription factor 2 gene (GRHL2) inhibits the proliferation, migration, invasion and mediates cell cycle arrest of ovarian cancer cells

D. Bachvarov, S. Gobeil, M. Plante, 2017, Cell cycle.

Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation

D. Bachvarov, M. Plante, J. Grégoire, 2014, Oncotarget.

Inhibition of RUNX2 Transcriptional Activity Blocks the Proliferation, Migration and Invasion of Epithelial Ovarian Carcinoma Cells

D. Bachvarov, S. Gobeil, M. Plante, 2013, PloS one.

Human epididymis protein 4 (HE4) and ovarian cancer prognosis.

I. Bairati, D. Bachvarov, D. Trudel, 2012, Gynecologic oncology.

A novel genome-based approach correlates TMPRSS3 overexpression in ovarian cancer with DNA hypomethylation.

D. Bachvarov, M. Plante, J. Grégoire, 2012, Gynecologic oncology.

Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancer

I. Bairati, D. Bachvarov, M. Plante, 2011, Molecular oncology.

Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial

Jacobus Pfisterer, Gordon C Jayson, Michael Quinn, 2015, The Lancet. Oncology.

The mannose receptor LY75 (DEC205/CD205) modulates cellular phenotype and metastatic potential of ovarian cancer cells

B. Vanderhyden, D. Bachvarov, S. Gobeil, 2016, Oncotarget.

Dataset for the Reporting of Carcinoma of the Cervix: Recommendations From the International Collaboration on Cancer Reporting (ICCR).

J. Ordi, A. Mills, C. Selinger, 2022, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

A phase 3 trial of bevacizumab in ovarian cancer.

Jacobus Pfisterer, Jalid Sehouli, Rainer Kimmig, 2011, The New England journal of medicine.

Hic-5 regulates epithelial to mesenchymal transition in ovarian cancer cells in a TGFβ1-independent manner

B. Vanderhyden, D. Bachvarov, S. Gobeil, 2017, Oncotarget.

Indication and Method of Frozen Section in Vaginal Radical Trachelectomy

M. Plante, J. Grégoire, M. Renaud, 2009, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Vaginal Radical Trachelectomy in the Treatment of Cervical Cancer: The Role of Frozen Section

M. Plante, M. Renaud, M. Roy, 2004, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Vaginal radical trachelectomy: an update.

M. Plante, 2008, Gynecologic oncology.

Lymph node metastases in low-grade endometrial stromal sarcoma.

M. Plante, M. Renaud, M. Roy, 2005, Gynecologic oncology.

Proposed novel nomenclature of vulvar smooth muscle tumors; a case of Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP) of the vulva

M. Plante, M. Renaud, K. Grondin, 2017, Gynecologic oncology reports.

Medical Treatment of Endometrial Carcinoma for the Premenopausal Woman Wanting to Preserve her Ability to Have Children

M. Plante, M. Renaud, 2001 .

Guidelines on Adenocarcinoma in situ of the Cervix: Clinical Features and Review of Management: These guidelines have been prepared by the SOGC/GOC/SCC Policy and Practice Guideline Committee and were approved by the Council of the SOGC

M. Plante, T. Ehlen, M. Heywood, 1999 .

Policy Statement: Guidelines for the Laparoscopic Management of the Adnexal Mass

P. Ghatage, M. Plante, T. Ehlen, 1998 .

Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer

B Richter, I Vergote, V. Gebski, 2011, British Journal of Cancer.

Proteases and their inhibitors as prognostic factors for high-grade serous ovarian cancer.

I. Bairati, R. Kappelhoff, C. Overall, 2019, Pathology, research and practice.

Prognostic significance of TIMP-2, MMP-2, and MMP-9 on high-grade serous ovarian carcinoma using digital image analysis.

I. Bairati, S. Turcotte, D. Trudel, 2015, Human pathology.

Cervical Cancer Prevention in Low-Resource Settings

Dianne Miller, J. McAlpine, L. Elit, 2011 .

Vaginal radical hysterectomy versus abdominal radical hysterectomy in the treatment of early-stage cervical cancer.

M. Plante, M. Roy, B. Têtu, 1996, Gynecologic oncology.

Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial.

P. Escobar, D. Urbauer, M. Plante, 2018, The Lancet. Oncology.

Sentinel lymph node procedure in endometrial cancer: A systematic review and proposal for standardization of future research.

W. Gotlieb, M. Plante, C. Giede, 2015, Gynecologic oncology.

SENTICOL III: an international validation study of sentinel node biopsy in early cervical cancer. A GINECO, ENGOT, GCIG and multicenter study

P. Hillemanns, R. Zweemer, E. Hudson, 2019, International Journal of Gynecological Cancer.

Is less more in the surgical treatment of early-stage cervical cancer?

M. Plante, C. Mom, N. V. van Trommel, 2022, Current opinion in oncology.

Isolated tumor cells identified by sentinel lymph node mapping in endometrial cancer: Does adjuvant treatment matter?

M. Plante, J. Grégoire, M. Renaud, 2017, Gynecologic oncology.

Negative sentinel lymph node accurately predicts negative status of pelvic lymph nodes in uterine cervix carcinoma.

M. Plante, M. Renaud, M. Roy, 2006, Gynecologic oncology.

Endometrial carcinoma molecular subtype correlates with the presence of lymph node metastases.

S. Leung, D. Huntsman, C. Gilks, 2022, Gynecologic oncology.

Simple Vaginal Trachelectomy: A Valuable Fertility-Preserving Option in Early-Stage Cervical Cancer

M. Plante, J. Grégoire, M. Renaud, 2017, International Journal of Gynecologic Cancer.

A GCIG international survey: clinical practice patterns of sentinel lymph node biopsies in cervical cancer

B. Monk, C. Denkert, J. Sehouli, 2019, Archives of Gynecology and Obstetrics.

Minimally Invasive Surgery for Cervical Cancer in Light of the LACC Trial: What Have We Learned?

M. Plante, O. Touhami, Omar Touhami, 2022, Current oncology.

Response to Maneo et al.

K. Swenerton, M. Plante, M. Roy, 2006 .

FIGO 2018 stage IB2 (2–4 cm) Cervical cancer treated with Neo-adjuvant chemotherapy followed by fertility Sparing Surgery (CONTESSA); Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility (NEOCON-F). A PMHC, DGOG, GCIG/CCRN and multicenter study

A. Oza, K. Sikorska, S. Lheureux, 2019, International Journal of Gynecological Cancer.

IGCS Intraoperative Technology Taskforce. Update on near infrared imaging technology: beyond white light and the naked eye, indocyanine green and near infrared technology in the treatment of gynecologic cancers

A. E. Bailey, R. Kimmig, R. Angioli, 2020, International Journal of Gynecological Cancer.

The FILM Trial: A randomized phase III multicenter study assessing near infrared fluorescence in the identification of sentinel lymph nodes (SLN)

P. Escobar, M. Munsell, M. Plante, 2018, Gynecologic Oncology.

Preoperative Bowel Preparation in Gynecologic Oncology: A Review of Practice Patterns and an Impetus to Change

J. McAlpine, M. Plante, T. Wells, 2011, International Journal of Gynecologic Cancer.

Effectiveness of an Enhanced Recovery After Surgery Program in Gynaecology Oncologic Surgery: A Single-Centre Prospective Cohort Study.

M. Plante, J. Grégoire, M. Renaud, 2019, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

A Collaborative Model to Implement Flexible, Accessible and Efficient Oncogenetic Services for Hereditary Breast and Ovarian Cancer: The C-MOnGene Study

J. Simard, Y. Joly, H. Nabi, 2021, Cancers.

Germline mutations in the breast cancer susceptibility gene PTEN are rare in high-risk non-BRCA1/2 French Canadian breast cancer families

Frédéric Guénard, Charles Joly Beauparlant, Francine Durocher, 2007, Familial Cancer.

Clinical management recommendations for surveillance and risk-reduction strategies for hereditary breast and ovarian cancer among individuals carrying a deleterious BRCA1 or BRCA2 mutation.

D. Horsman, W. Meschino, J. Simard, 2007, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

Genetic variants and haplotype analyses of the ZBRK1/ZNF350 gene in high‐risk non BRCA1/2 French Canadian breast and ovarian cancer families

Y. Labrie, J. Chiquette, R. Laframboise, 2008, International journal of cancer.

Characterization of common UGT1A8, UGT1A9, and UGT2B7 variants with different capacities to inactivate mutagenic 4-hydroxylated metabolites of estradiol and estrone.

Yannick Duguay, Louis Perusse, Bernard Têtu, 2006, Cancer research.

Platinum versus platinum-combination chemotherapy in platinum-sensitive recurrent ovarian cancer: a meta-analysis using individual patient data.

D. Alberts, M. Parmar, V. Torri, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death.

A. Talhouk, S. Leung, D. Huntsman, 2023, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancer.

A. Talhouk, S. Leung, D. Huntsman, 2023, Gynecologic oncology.

Variability in endometrial carcinoma pathology practice: opportunities for improvement with molecular classification

A. Talhouk, S. Leung, A. Tinker, 2022, Modern Pathology.

D. Bachvarov, J. Masson, M. Plante, 2020, Journal of translational medicine.

The use of operative laparoscopy in determining eligibility for pelvic exenteration in patients with recurrent cervical cancer.

M. Plante, M. Roy, 1995, Gynecologic oncology.

Immunohistochemical analysis of possible chemoresistance markers identified by micro-arrays on serous ovarian carcinomas

I. Bairati, D. Bachvarov, M. Plante, 2008, Modern Pathology.

Association of nivolumab and niraparib in the management of neuroendocrine cancer of the cervix

M. Plante, M. Frumovitz, Omar Touhami, 2023, International Journal of Gynecological Cancer.

Fertility-preserving options for cervical cancer.

M. Plante, M. Roy, 2006, Oncology.

Options in the management of fertility-related issues after radical trachelectomy in patients with early cervical cancer.

P. Ramirez, M. Plante, N. Abu-Rustum, 2009, Gynecologic Oncology.

Extensive adipose tissue necrosis following pfannenstiel incision for endometrial cancer.

M. Plante, J. Grégoire, M. Renaud, 2014, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

Evaluation of Morbidity of Suction Drains After Retroperitoneal Lymphadenectomy in Gynecological Tumors: A Systematic Literature Review

M. Plante, M. Edelweiss, O. Bacha, 2008, International Journal of Gynecologic Cancer.

Vaginal radical trachelectomy

M. Plante, Y. Sonoda, M. Renaud, 2008 .

New approaches in the surgical management of early stage cervical cancer

M. Plante, M. Roy, 2001, Current opinion in obstetrics & gynecology.

Radical vaginal trachelectomy: a fertility-preserving option for young women with early stage cervical cancer.

M. Plante, M. Renaud, M. Roy, 2005, Gynecologic oncology.

Evolution in Fertility-Preserving Options for Early-Stage Cervical Cancer: Radical Trachelectomy, Simple Trachelectomy, Neoadjuvant Chemotherapy

M. Plante, 2013, International Journal of Gynecologic Cancer.

Place of Schauta's radical vaginal hysterectomy.

M. Plante, M. Roy, 2011, Best practice & research. Clinical obstetrics & gynaecology.

Laparoscopically assisted vaginal radical hysterectomy.

M. Plante, M. Renaud, M. Roy, 2005, Best practice & research. Clinical obstetrics & gynaecology.

PREGNANCIES AFTER RADICAL VAGINAL TRACHELECTOMY FOR EARLY-STAGE CERVICAL CANCER

M. Plante, M. Roy, 1999 .

PREGNANCY AFTER RADICAL VAGINAL TRACHELECTOMY. AUTHORS' REPLY

M. Plante, M. Roy, R. Jelsema, 1999 .

Primitive clear cell carcinoma of the vagina treated conservatively.

M. Plante, J. Grégoire, M. Renaud, 2009, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

The technicity index: a useful performance indicator for minimally invasive surgery in the management of endometrial cancer.

M. Plante, M. Renaud, M. Roy, 2012, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

Laparoscopic surgery for endometrial cancer: a review.

B. Rosen, W. Gotlieb, M. Plante, 2010, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

Ovarian thecoma associated with a large quantity of ascites and elevated serum CA 125 and CA 15-3.

M. Plante, M. Renaud, M. Roy, 2002, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

Breast and ovarian cancer screening of non-carriers from BRCA1/2 mutation-positive families: 2-year follow-up of cohorts from France and Quebec

J. Simard, M. Dorval, C. Lasset, 2011, European Journal of Human Genetics.

An in-home rehabilitation program for the treatment of urinary incontinence symptoms in endometrial cancer survivors: a single-case experimental design study

H. Moffet, L. McLean, L. Hébert, 2021, International Urogynecology Journal.

Identification of Metabolomic Biomarkers for Endometrial Cancer and Its Recurrence after Surgery in Postmenopausal Women

C. Guillemette, M. Plante, J. Grégoire, 2018, Front. Endocrinol..

Reliability of core needle biopsy for determining ER and HER 2 status in breast cancer

V. Gebski, R. Simes, G. Kristensen, 2013 .

Robotic-assisted surgery for endometrial cancer is safe in morbidly and extremely morbidly obese patients.

M. Plante, M. Renaud, Juliette Bernard, 2023, Gynecologic oncology.

Utility of PET/CT to Evaluate Retroperitoneal Lymph Node Metastasis in High-Risk Endometrial Cancer: Results of ACRIN 6671/GOG 0233 Trial.

S. King, Shamshad Ali, R. Mannel, 2017, Radiology.

Oncologic Outcomes of Surgically Treated Cervical Cancer with No Residual Disease on Hysterectomy Specimen: A 4C (Canadian Cervical Cancer Collaborative) Working Group Study

G. Pond, J. Kwon, L. Elit, 2023, Current oncology.

Circulating adrenal 11-oxygenated androgens are associated with clinical outcome in endometrial cancer

C. Guillemette, M. Plante, J. Grégoire, 2023, Frontiers in Endocrinology.

PLATINUM COMBINATION CHEMOTHERAPY VERSUS PLATINUM MONOTHERAPY IN PLATINUM-SENSITIVE RECURRENT OVARIAN CANCER: A META-ANALYSIS OF RANDOMISED TRIALS USING INDIVIDUAL PATIENT DATA (IPD)

D. Alberts, M. Parmar, J. Ledermann, 2012 .

Evaluating the diagnostic performance of preoperative endometrial biopsies in patients diagnosed with high grade endometrial cancer: A study of the Society of Gynecologic Oncology (GOC) Community of Practice (CoP).

J. Kwon, S. Lau, W. Gotlieb, 2020, Gynecologic oncology.

Factors associated with an increased risk of recurrence in patients diagnosed with high-grade endometrial cancer undergoing minimally invasive surgery: A study of the society of gynecologic oncology (GOC) community of practice (CoP).

J. Kwon, S. Lau, W. Gotlieb, 2021, Gynecologic oncology.

Primary villoglandular adenocarcinoma of cloacogenic origin of the vulva.

M. Plante, V. Dubé, C. Veilleux, 2004, Human pathology.

A phase 2, single agent study of CI-1033 administered at two doses in ovarian cancer patients who failed platinum therapy.

A. Oza, H. Hirte, E. Kaldjian, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gene expression patterns of chemoresistant and chemosensitive serous epithelial ovarian tumors with possible predictive value in response to initial chemotherapy.

Bernard Têtu, Magdalena Bachvarova, Dimcho Bachvarov, 2006, International journal of oncology.

Identification of six new susceptibility loci for invasive epithelial ovarian cancer

Yurii B. Shvetsov, Simon G. Coetzee, Dennis J. Hazelett, 2014, Nature Genetics.

Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial.

H. Mackay, A. Oza, M. Friedlander, 2015, The Lancet. Oncology.

Pilot Study of Radical Hysterectomy Versus Radical Trachelectomy on Sexual Distress

M. Plante, Kelly B. Smith, L. Brotto, 2013, Journal of sex & marital therapy.

Dataset for the Reporting of Carcinoma of the Cervix: Recommendations From the International Collaboration on Cancer Reporting (ICCR)

J. Ordi, C. Otis, I. Alvarado-Cabrero, 2022, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Value of sentinel node mapping in cancer of the cervix.

M. Plante, J. Grégoire, M. Renaud, 2011, Gynecologic oncology.

The RUNX1 transcription factor is expressed in serous epithelial ovarian carcinoma and contributes to cell proliferation, migration and invasion

D. Bachvarov, M. Plante, X. Trinh, 2013, Cell cycle.

Isolated tumor cells identified by sentinel lymph node mapping in endometrial cancer: Does adjuvant treatment matter?

M. Plante, J. Grégoire, M. Renaud, 2017, Gynecologic oncology.

Sentinel node mapping with indocyanine green and endoscopic near-infrared fluorescence imaging in endometrial cancer. A pilot study and review of the literature.

M. Plante, X. Trinh, J. Grégoire, 2015, Gynecologic oncology.

The case of a viable pregnancy post vaginal radical trachelectomy followed by combined chemo-radiation therapy.

M. Plante, S. Cox, K. Silverberg, 2011, Gynecologic oncology.